Clinical trials
Withdrawn Phase 2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Gynecologic Oncology Group | 2 |
| AGO Research GmbH | 1 |
| Alexander B Olawaiye, MD | 1 |
| Andrea McCart | 1 |
| AstraZeneca | 1 |
| Australia New Zealand Gynaecological Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| EMD Serono | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 26 |
| Fallopian Tube Neoplasms | 8 |
| Carcinoma, Ovarian Epithelial | 6 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
| Carcinoma | 1 |
| Carcinosarcoma | 1 |
| Endophthalmitis | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.